Eating disorders surge as GLP-1 weight-loss drugs raise misuse concerns
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Global anorexia and bulimia incidence rose 71% from 1990 to 2023, with an estimated 18.1 million people living with those disorders by 2023. Clinicians report GLP-1 drugs are being misused by people with eating disorders and may worsen symptoms; University of Louisville psychologist Cheri Levinson says she is seeing the most severe cases in nearly 20 years.
Continue in the app — vote & join in ➔Source: MIT Technology Review · via ahirlevel.hu